News, Analysis & Insights on Nutrition, Supplements, and Health
FDA is taking another look at how it interprets the statutory definition of a dietary substance, a move that could have implications for novel ingredients seeking a path to market, according to Cara Welch, PhD, director of the agency’s Office of Dietary...
Before the revisions, companies using fermentation-derived bioactives could face additional requests for evidence about their ingredient sources or production methods, even when the intended use was already covered by Health Canada’s pre-cleared information.
This week’s brief tracks news that highlights the strategic importance of scientific substantiation, safety data, and regulatory readiness as increasingly important competitive advantages.
Dietary supplement companies should consider intellectual property protection early in product development to safeguard innovation and reduce risk of infringing existing patents, according to Peter Paredes and George Carrera, Jr. of Amin, Wasserman and...
The Council for Responsible Nutrition (CRN) is pursuing regulatory changes to improve certainly for supplement companies, from drug preclusion and ingredient grandfathering to the future of self-affirmed GRAS, said president and CEO Steve Mister.
As the US Food and Drug Administration (FDA) considers how to modernize dietary supplement oversight, Cara Welch, PhD, director of FDA’s Office of Dietary Supplement Programs, has emphasized the agency’s commitment to keeping pace with an evolving...
This week’s brief tracks news that highlights the stricter compliance requirements and stronger technology-based differentiation.
The U.S. Food and Drug Administration’s (USFDA) assessment of gummy supplements production, Australia’s stricter rules on andrographis use and New Zealand’s upcoming revisions to its natural health products export policies are some of the latest updates...
Opinion piece
Industry agrees that drug preclusion is broken and in need of reform. We all saw what happened with NAC and NMN. And we want dietary supplement companies to have greater certainty before investing millions of dollars developing and marketing an ingredient.
As retailers and regulators demand greater confidence in product quality, brands are taking a closer look at what their testing actually proves.
Opinion piece
CRN, CHPA and AHPA are celebrating H.R. 10336 as a balanced compromise. But in the pursuit of regulatory certainty, has part of the supplement industry agreed to permanently enshrine the very pharmaceutical gatekeeping mechanism it has spent years fighting?
The Sports & Active Nutrition Summit USA (SANS USA) is heading to Dallas in 2027 after two consecutive sold-out editions in San Diego.
This week’s brief tracks news that highlights the industry’s shift towards a future defined by stronger regulatory oversight, greater scientific substantiation, export-focused regulatory reform, and growing sustainability expectations.
A recent case decision offers a closer look at how the National Advertising Division (NAD) approaches ingredient-level research when companies make claims for multi-ingredient products, including when that evidence can be extrapolated to the finished...
NutraIngredients at 25
As NutraIngredients celebrates 25 years, Global Editor-in-Chief Stephen Daniells, PhD, looks back at the 20+ years he has been with the publication. From the early days of digital publishing to the rise of social media, podcasts, video and now AI,...
A lawmaker in New Jersey has filed a bill to prohibit the sale of weight loss and muscle building products to minors, part of a broader trend of state-level efforts to restrict youth access to certain dietary supplements.
Multilevel marketing giant Amway and two Amway licensees will pay $225 million to resolve allegations from the Federal Trade Commission and the state of Washington for alleged unfair and deceptive tactics.
From social media pseudoscience and influencer culture to industry advocacy and trend-chasing, Future Nutra Innovation Summit (FNIS) attendees outlined where they see gaps — and what could change them.
As the dust settles on Russia’s takeover of Nestlé’s local operations, analysts warn the move could reshape how multinationals assess risk in the country
The next five years of nutraceutical innovation could be defined less by a single breakthrough ingredient and more by the convergence of technology, nature, new delivery formats and changing consumer behavior, according to industry leaders at the Future...
For centuries, coca leaf has played an important cultural and traditional role in the Andes. But outside South America, the plant is far more likely to be associated with one thing: cocaine. So what happens when we separate the coca leaf from the drug...
FDA wants companies to notify the agency when they determine food ingredients are Generally Recognized As Safe. But with hundreds of potential notifications and fewer staff, questions remain over whether FDA has the resources to review them
Synthetic spokespeople may be new, but industry experts say brands remain responsible for substantiated claims, truthful endorsements and transparent marketing.
The dietary supplement industry is facing a new layer of supply-chain uncertainty as geopolitical tensions, tariffs, energy prices and freight disruptions ripple through the global ingredient market.
Dr. Heidi Overton was nominated by President Donald Trump to lead the Food and Drug Administration, the White House announced Wednesday.
Quten Research Institute is facing a proposed class action alleging that its Qunol Ultra Omega-3 Fish Oil contains less omega-3 than the 1,000 mg advertised on the product label.
Connected wellness products offer supplement companies opportunities to reach beyond traditional categories, but that move may also expose them to new safety requirements and closer regulatory scrutiny.
Venable’s Todd Harrison questions FDA’s authority to mandate Generally Recognized As Safe (GRAS) notifications and says the proposal could create significant uncertainty for ingredient suppliers and functional food and beverage companies.
The dispute highlights how competing measures of market leadership can determine which supplement brands are able to claim the top spot.
Canomiks’ evidence-based platform aims to help consumers distinguish product-specific science from marketing claims while encouraging greater transparency across the dietary supplement industry.
Ryse Up Sports Nutrition is facing a proposed class action alleging its Ryse Clear Protein Drinks contain between 6% and 11% less protein than the 22 g declared on the label.
The proposed legislation would establish a federal regulatory framework for hemp-derived cannabinoid products, which industry stakeholders say could provide long-sought regulatory certainty for manufacturers and create a clearer pathway for nutrition and...
The United States Patent and Trademark Office has issued The Akkermansia Company (TAC) with a new patent, granting the company the exclusive right to market Akkermansia for metabolic disorders.
In response, TruHeight stated it has already implemented broader compliance measures, including external regulatory oversight and updated review policies.
Catch up with our weekly round-up of key news from across the Nutraverse.